Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 27;14:17588359221108687. doi: 10.1177/17588359221108687

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2022

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Distribution of the anti-spike antibody levels at T1, T2, and T3. Distributions of the antibody titer of the 171 patients at different timepoints (T1, T2, and T3). Each box indicates the 25th and 75th percentiles. The horizontal line and the diamond inside the box indicate the median and the mean, respectively. Whiskers indicate the extreme measured values. Patients with a negative titer after the first dose (T1) are represented with different colors to identify them and evaluate their dynamics of seroconversion in T2 and T3.